Repušnica (HR)
{name}
{subtitle}
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~57 mi. (Zagreb, Croatia, +144 more cities)
facility
Klinicki Bolnicki Centar Zagreb ( Site 3200)
condition
Clear Cell Renal Cell Carcinoma
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis
city
~57 mi. (Zagreb, Croatia, +165 more cities)
facility
Klinicki bolnicki centar Zagreb /ID# 230793, +2 more facilities
biomarker
del(11)(q10), +27 more biomarkers
condition
Myelofibrosis
drug
navitoclax, +1 more drug
drug type
targeted therapy
A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm
city
~57 mi. (Zagreb, Croatia, +42 more cities)
facility
Klinicki bolnicki centar Zagreb /ID# 240140
condition
Chronic Myelomonocytic Leukemia, +3 more conditions
drug
celecoxib, +2 more drugs
drug type
Other, +1 more type